Peter Wolfe - Dec 16, 2022 Form 4 Insider Report for ZyVersa Therapeutics, Inc. (ZVSA)

Role: Chief Financial Officer
Signature: /s/ Peter Wolfe
Stock symbol: ZVSA
Transactions as of: Dec 16, 2022
Transactions value $: $8,645
Form type: 4
Date filed: 12/20/2022, 03:00 PM
Previous filing: Dec 13, 2022
Next filing: Jul 18, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ZVSA	Common Stock	Award	$8.64K	+3K	+7.21%	$2.88^*	44.6K	Dec 16, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.78 to $2.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.78 to $2.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.